10X Genomics Inc (TXG)
Healthcare
Health Information Services
47.30 $
-4.4%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns 10X Genomics Inc (TXG)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 98.2% of the shares are freely tradable; institutional investors hold 113.8%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
113.8%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
1.7%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
98.2%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
25.9%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
117Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| FMR Inc | 13.97 | 17,740,972 | +48.9 | 03/31/2026 |
| Vanguard Group Inc | 10.25 | 13,017,914 | -1.9 | 12/31/2025 |
| ARK Investment Management LLC | 9.23 | 11,717,317 | -7.5 | 03/31/2026 |
| BlackRock Inc | 7.94 | 10,079,913 | +0.7 | 03/31/2026 |
| Vanguard Portfolio Management, LLC | 5.45 | 6,912,936 | +0.0 | 03/31/2026 |
| Quantinno Capital Management LP | 4.26 | 5,411,761 | +16.0 | 03/31/2026 |
| Vanguard Capital Management, LLC | 4.15 | 5,269,586 | +0.0 | 03/31/2026 |
| Sumitomo Mitsui Trust Group Inc | 4.03 | 5,110,214 | -7.0 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| ARK Innovation ETF | 5.53 | 7,024,575 | +2.3 | 05/31/2026 |
| ARK Disruptive Innovation Full Composite | 5.52 | 7,004,755 | -8.9 | 03/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.